Significantly increasing rates of antimicrobial resistance were found in clinical Campylobacter jejuni isolated in China between 1994 and 2010.
Macrolides are still the most effective antibiotics for human campylobacteriosis in this region.
The molecular mechanisms including 23S rRNA, ermB, and the regulatory region of the CmeABC operon might be involved in erythromycin resistance.
This study revealed that more stringent monitoring and regulation of human and animal antimicrobial use is warranted in this region.